Oligonucleotide Synthesis Market – Analysis and Forecast To 2024 | Eurogentec, GE Healthcare.

Oligonucleotide synthesis is used in various applications such as next-generation sequencing (NGS) methods, nucleic acid array-based technologies, therapeutics, library preparations, human identity testing, genomics, nucleic acid-base detections, cell cultures, cloning, diagnostics, and genetic engineering and synthetic biology. The global oligonucleotide synthesis market is growing at a significant rate, due to the mounting usage of synthesized oligonucleotides in molecular diagnostics and clinical applications, and intensifying demand for synthesized oligonucleotides.

Download Free Report Sample At: https://www.vynzresearch.com/healthcare/oligonucleotide-synthesis-market/request-sample

Price erosion of synthesized oligonucleotides, lack of a unified set of regulations for therapeutic oligonucleotides, large-scale synthesis of oligonucleotides, and delivery of oligonucleotide drugs to specific targets are the major challenges for the growth of oligonucleotide synthesis market.

Globally, the manufacturing companies trying to enter the oligonucleotide synthesis market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier to the entry of new players. This offers an edge to the established players in the industry competition.

Asia-Pacific is observed to witness the fastest growth in the market, due to the mounting accessibility of synthesized oligos. In addition, the mounting need for better healthcare outcome, the upsurge in R&D funding, improving healthcare infrastructure and activities and escalating government funding are also creating a positive impact on the oligonucleotide synthesis market growth in the region.

Read More: https://www.vynzresearch.com/healthcare/oligonucleotide-synthesis-market

Key players in the oligonucleotide synthesis market are catering to the demand of these devices by investing in technologically advanced products in their product portfolio across the globe. In October 2016, Nitto Denko Avecia Inc. acquired Irvine Pharmaceutical Services and Avrio Biopharmaceuticals, to expand its oligonucleotide drug business.

Merck KGaA, Agilent Technologies, LGC Biosearch Technologies, Eurofins Genomics, Eurogentec, GE Healthcare, Thermo Fisher Scientific, and Nitto Denko Avecia Inc. are the key players offering oligonucleotide synthesis.

About VynZ Research
VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies.

Contact

Manager: Client Care

Toll-Free: 18882533960

Email: kundan@vynzresearch.com

Website: www.vynzresearch.com